Page last updated: 2024-11-02

oxidopamine and Liver Dysfunction

oxidopamine has been researched along with Liver Dysfunction in 4 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research Excerpts

ExcerptRelevanceReference
" The cytoprotective effect of central TRH on CCl(4)-induced acute hepatocellular necrosis was abolished by hepatic branch vagotomy, atropine, indomethacin and N(G)-nitro-L-arginine methyl ester, but not by 6-hydroxydopamine."7.72Protective effect of central thyrotropin-releasing hormone on carbon tetrachloride-induced acute hepatocellular necrosis in rats. ( Makino, I; Nakamura, K; Sato, Y; Terano, A; Yoneda, M, 2003)
" The cytoprotective effect of central TRH on CCl(4)-induced acute hepatocellular necrosis was abolished by hepatic branch vagotomy, atropine, indomethacin and N(G)-nitro-L-arginine methyl ester, but not by 6-hydroxydopamine."3.72Protective effect of central thyrotropin-releasing hormone on carbon tetrachloride-induced acute hepatocellular necrosis in rats. ( Makino, I; Nakamura, K; Sato, Y; Terano, A; Yoneda, M, 2003)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sato, Y1
Yoneda, M3
Nakamura, K3
Makino, I3
Terano, A2
Oben, JA1
Roskams, T1
Yang, S1
Lin, H1
Sinelli, N1
Li, Z1
Torbenson, M1
Huang, J1
Guarino, P1
Kafrouni, M1
Diehl, AM1
Yokohama, S1
Nakade, Y1

Other Studies

4 other studies available for oxidopamine and Liver Dysfunction

ArticleYear
Protective effect of central thyrotropin-releasing hormone on carbon tetrachloride-induced acute hepatocellular necrosis in rats.
    Journal of hepatology, 2003, Volume: 39, Issue:1

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atropine; Carbon Tetrachloride; Che

2003
Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury.
    Hepatology (Baltimore, Md.), 2003, Volume: 38, Issue:3

    Topics: Adrenergic alpha-Antagonists; Animals; Antioxidants; Body Weight; Diet; Fatty Liver; Hepatocytes; Li

2003
Effect of central corticotropin-releasing factor on carbon tetrachloride-induced acute liver injury in rats.
    The American journal of physiology, 1999, Volume: 276, Issue:3

    Topics: Acute Disease; Animals; Atropine; Brain; Carbon Tetrachloride; Chemical and Drug Induced Liver Injur

1999
Involvement of endogenous CRF in carbon tetrachloride-induced acute liver injury in rats.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2002, Volume: 282, Issue:6

    Topics: Acute Disease; Alanine Transaminase; Animals; Atropine Derivatives; Carbon Tetrachloride; Chemical a

2002